Growth Metrics

Lucid Diagnostics (LUCD) EBT Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -2.47%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.70%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 37.81%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.82%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 32.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 61.06%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.57%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 14.40%
10 Lucid Diagnostics 145.00 Mn 117.12 Mn -325,000.00 5.05%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.05%
Dec 31, 2025 -2.90%
Sep 30, 2025 10.18%
Jun 30, 2025 32.79%
Mar 31, 2025 -29.92%
Dec 31, 2024 -0.69%
Sep 30, 2024 -21.15%
Jun 30, 2024 -21.32%
Mar 31, 2024 -42.69%
Dec 31, 2023 -58.28%
Sep 30, 2023 -91.55%